FOLH1 and neoplasm: In conclusion, inclusion of an N-bromobenzyl substituent promoted increased PSMA+ PIP tumor uptake, while a hydrophilic linker, particularly with the inclusion of PEG, may decrease nonspecific binding, particularly to the kidney, in this new series of PSMA-targeted NIR agents.